PEGylated exendin-4, a modified GLP-1 analog exhibits more potent cardioprotection than its unmodified parent molecule on a dose to dose basis in a murine model of myocardial infarction
Statements describing expected buyer outcomes, program structures, or regulatory trends are educational observations, not guarantees
Professional and academic interests are minimised as much as possible, while maintaining necessary expertise on the panel to make fully informed decisions
Compounds such as PT-141 (Bremelanotide), Kisspeptin, and Melanotan 1 are being explored for possible roles in sexual function, hormone signaling, and metabolism
PAK4-NAMPT dual inhibition as a novel strategy for therapy resistant pancreatic neuroendocrine tumors